NASDAQ Biotechnology Index (NBI) Market Capitalization
Explore all companies in the NASDAQ Biotechnology Index ranked by market capitalization
Total Market Cap: $1.54 Trillion Constituents: 263 Country: USA
Total Market Cap (USD)
$1.54 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 1 |
AstraZeneca PLC
NASDAQ:AZN |
% | $296.35 Billion | Healthcare | Drug Manufacturers - General | $192.01 | +1.11% |
| 2 |
Amgen Inc
NASDAQ:AMGN |
% | $196.91 Billion | Healthcare | Drug Manufacturers - General | $366.25 | +0.01% |
| 3 |
Gilead Sciences Inc
NASDAQ:GILD |
% | $179.76 Billion | Healthcare | Drug Manufacturers - General | $145.21 | +0.15% |
| 4 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
% | $118.01 Billion | Healthcare | Biotechnology | $466.10 | -0.69% |
| 5 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
% | $74.58 Billion | Healthcare | Biotechnology | $756.91 | +1.49% |
| 6 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
% | $42.14 Billion | Healthcare | Biotechnology | $318.91 | +1.75% |
| 7 |
Insmed Inc
NASDAQ:INSM |
% | $27.67 Billion | Healthcare | Biotechnology | $144.60 | +3.66% |
| 8 |
Biogen Inc
NASDAQ:BIIB |
% | $26.81 Billion | Healthcare | Drug Manufacturers - General | $183.26 | +0.94% |
| 9 |
United Therapeutics Corporation
NASDAQ:UTHR |
% | $21.40 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $534.30 | -0.34% |
| 10 |
Moderna Inc
NASDAQ:MRNA |
% | $19.64 Billion | Healthcare | Biotechnology | $53.31 | +1.43% |
| 11 |
Royalty Pharma Plc
NASDAQ:RPRX |
% | $18.09 Billion | Healthcare | Biotechnology | $46.10 | +0.99% |
| 12 |
Illumina Inc
NASDAQ:ILMN |
% | $17.74 Billion | Healthcare | Diagnostics & Research | $119.28 | +0.29% |
| 13 |
Revolution Medicines Inc
NASDAQ:RVMD |
% | $17.23 Billion | Healthcare | Biotechnology | $99.00 | +4.36% |
| 14 |
Incyte Corporation
NASDAQ:INCY |
% | $15.49 Billion | Healthcare | Biotechnology | $93.00 | +0.50% |
| 15 |
Viatris Inc
NASDAQ:VTRS |
% | $15.45 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $13.50 | -0.07% |
| 16 |
Roivant Sciences Ltd
NASDAQ:ROIV |
% | $14.91 Billion | Healthcare | Biotechnology | $28.28 | +0.78% |
| 17 |
Ascendis Pharma AS
NASDAQ:ASND |
% | $14.06 Billion | Healthcare | Biotechnology | $231.03 | +2.23% |
| 18 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
% | $12.86 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $129.85 | +0.05% |
| 19 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
% | $11.61 Billion | Healthcare | Biotechnology | $72.34 | +1.62% |
| 20 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
% | $11.04 Billion | Healthcare | Biotechnology | $71.03 | +2.33% |
| 21 |
Guardant Health Inc
NASDAQ:GH |
% | $11.01 Billion | Healthcare | Diagnostics & Research | $87.18 | +1.98% |
| 22 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
% | $10.99 Billion | Healthcare | Biotechnology | $57.43 | -1.85% |
| 23 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
% | $10.86 Billion | Healthcare | Biotechnology | $182.02 | +1.94% |
| 24 |
Medpace Holdings Inc
NASDAQ:MEDP |
% | $10.36 Billion | Healthcare | Diagnostics & Research | $453.64 | +0.72% |
| 25 |
BioNTech SE
NASDAQ:BNTX |
% | $9.05 Billion | Healthcare | Biotechnology | $90.54 | -0.71% |
| 26 |
Exelixis Inc
NASDAQ:EXEL |
% | $8.66 Billion | Healthcare | Biotechnology | $41.07 | -0.41% |
| 27 |
Blueprint Medicines Corp
NASDAQ:BPMC |
% | $7.77 Billion | Healthcare | Biotechnology | $129.46 | +0.14% |
| 28 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
% | $7.47 Billion | Healthcare | Biotechnology | $64.29 | +0.99% |
| 29 |
Cytokinetics Inc
NASDAQ:CYTK |
% | $7.39 Billion | Healthcare | Biotechnology | $60.83 | +1.28% |
| 30 |
Vaxcyte Inc
NASDAQ:PCVX |
% | $7.36 Billion | Healthcare | Biotechnology | $55.62 | +1.91% |
| 31 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
% | $6.84 Billion | Healthcare | Biotechnology | $158.23 | +1.38% |
| 32 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
% | $6.75 Billion | Healthcare | Biotechnology | $305.00 | +3.76% |
| 33 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
% | $6.71 Billion | Healthcare | Biotechnology | $57.37 | +4.21% |
| 34 |
Merus BV
NASDAQ:MRUS |
% | $6.30 Billion | Healthcare | Biotechnology | $90.00 | -7.14% |
| 35 |
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM |
% | $5.74 Billion | Healthcare | Health Information Services | $50.88 | +1.80% |
| 36 |
Krystal Biotech Inc
NASDAQ:KRYS |
% | $5.72 Billion | Healthcare | Biotechnology | $250.16 | +1.17% |
| 37 |
Cogent Biosciences Inc
NASDAQ:COGT |
% | $5.38 Billion | Healthcare | Biotechnology | $35.68 | +4.94% |
| 38 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
% | $5.30 Billion | Healthcare | Biotechnology | $440.83 | -0.90% |
| 39 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
% | $5.02 Billion | Healthcare | Biotechnology | $90.51 | +3.58% |
| 40 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
% | $4.87 Billion | Healthcare | Biotechnology | $92.64 | +2.18% |
| 41 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
% | $4.82 Billion | Healthcare | Biotechnology | $96.75 | +4.75% |
| 42 |
Crispr Therapeutics AG
NASDAQ:CRSP |
% | $4.63 Billion | Healthcare | Biotechnology | $48.42 | -0.68% |
| 43 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
% | $4.48 Billion | Healthcare | Biotechnology | $14.37 | +0.00% |
| 44 |
Nuvalent Inc
NASDAQ:NUVL |
% | $4.45 Billion | Healthcare | Biotechnology | $99.53 | +1.63% |
| 45 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
% | $4.36 Billion | Healthcare | Biotechnology | $65.90 | +2.50% |
| 46 |
Alkermes Plc
NASDAQ:ALKS |
% | $4.31 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $28.00 | +0.86% |
| 47 |
Arcellx Inc
NASDAQ:ACLX |
% | $4.04 Billion | Healthcare | Biotechnology | $114.51 | +0.10% |
| 48 |
Akero Therapeutics Inc
NASDAQ:AKRO |
% | $3.89 Billion | Healthcare | Biotechnology | $54.65 | +0.00% |
| 49 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
% | $3.87 Billion | Healthcare | Biotechnology | $56.65 | +5.40% |
| 50 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
% | $3.86 Billion | Healthcare | Biotechnology | $79.60 | +0.72% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices